Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Insulet Corporation stock
Learn how to easily invest in Insulet Corporation stock.
Insulet Corporation is a medical devices business based in the US. Insulet Corporation shares (PODD) are listed on the NASDAQ and all prices are listed in US Dollars. Insulet Corporation employs 2,600 staff and has a trailing 12-month revenue of around $1.3 billion.
How to buy Insulet Corporation stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PODD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Insulet Corporation stock price (NASDAQ: PODD)Use our graph to track the performance of PODD stocks over time.
Insulet Corporation shares at a glance
|Latest market close||$310.17|
|52-week range||$181.00 - $326.74|
|50-day moving average||$295.17|
|200-day moving average||$268.17|
|Wall St. target price||$335.07|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.06|
Buy Insulet Corporation stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Insulet Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Insulet Corporation price performance over time
Historical closes compared with the close of $310.17 from 2023-03-24
|1 week (2023-03-21)||-4.86%|
|1 month (2023-02-28)||12.23%|
|3 months (2022-12-28)||6.94%|
|6 months (2022-09-28)||31.35%|
|1 year (2022-03-28)||22.39%|
|2 years (2021-03-26)||16.26%|
|3 years (2020-03-27)||76.48%|
|5 years (2018-03-28)||265.03%|
Is Insulet Corporation stock undervalued or overvalued?
Valuing Insulet Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Insulet Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Insulet Corporation's P/E ratio
Insulet Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5170x. In other words, Insulet Corporation shares trade at around 5170x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Insulet Corporation's PEG ratio
Insulet Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.3234. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Insulet Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Insulet Corporation's EBITDA
Insulet Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $126 million.
The EBITDA is a measure of a Insulet Corporation's overall financial performance and is widely used to measure a its profitability.
Insulet Corporation financials
|Revenue TTM||$1.3 billion|
|Operating margin TTM||4.81%|
|Gross profit TTM||$805.6 million|
|Return on assets TTM||1.83%|
|Return on equity TTM||0.89%|
|Market capitalisation||$21.8 billion|
TTM: trailing 12 months
Insulet Corporation share dividends
We're not expecting Insulet Corporation to pay a dividend over the next 12 months.
Insulet Corporation share price volatility
Over the last 12 months, Insulet Corporation's shares have ranged in value from as little as $181 up to $326.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Insulet Corporation's is 0.7439. This would suggest that Insulet Corporation's shares are less volatile than average (for this exchange).
Insulet Corporation overview
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. .
Insulet Corporation in the news
The Zacks Analyst Blog Highlights Comfort Systems, Hershey, Wynn Resorts, Insulet and Lattice Semiconductor
Insulet (PODD) Stock Sinks As Market Gains: What You Should Know
Insulet's (NASDAQ:PODD) Returns On Capital Are Heading Higher
Frequently asked questionsWhat percentage of Insulet Corporation is owned by insiders or institutions?
Currently 0.461% of Insulet Corporation shares are held by insiders and 102.54% by institutions. How many people work for Insulet Corporation?
Latest data suggests 2,600 work at Insulet Corporation. When does the fiscal year end for Insulet Corporation?
Insulet Corporation's fiscal year ends in December. Where is Insulet Corporation based?
Insulet Corporation's address is: 100 Nagog Park, Acton, MA, United States, 01720 What is Insulet Corporation's ISIN number?
Insulet Corporation's international securities identification number is: US45784P1012 What is Insulet Corporation's CUSIP number?
Insulet Corporation's Committee on Uniform Securities Identification Procedures number is: 45784P101
More guides on Finder
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
How to buy gold
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert